Introduction
In the rat paracetamol is absorbed from all parts of the gastrointestinal tract including the stomach and the colon, although the most efficient uptake occurs in the small intestine by a passive transport process [1] . However, comparable information is not available for man. Paracetamol is generally considered to be absorbed rapidly from the small intestine, with little or no uptake from the stomach [2] [3] [4] [5] . To our knowledge, this has never been proven and the exact site of intestinal absorption has not been defined. We have measured serial serum concentrations of paracetamol after its oral administration to patients with total gastrectomy, distal partial gastrectomy, pylorus preserving pancreatoduodenectomy (PPPD), and short bowel syndrome, as well as in healthy subjects with normal bowels, to determine the main absorption site of paracetamol in the human gastrointestinal tract. portion of the duodenum was preserved. After completing the resection with the head of the pancreas, reconstruction was accomplished with a Billroth I type end-to-end anastomosis between the first and fourth portion of the duodenum. Pancreatojejunostomy and choledochojejunostomy were performed as described previously [6, 7] . Short bowel syndrome patients comprised one patient (#1) with a duodenostomy 15 cm distal from the pyloric ring following a traffic accident, one patient (#2) with a jejunostomy 15 cm distal from the DJF to treat paraquat intoxication, two (#3 and 4) patients with jejunostomies 40 cm distal from the DJF to treat Crohn's disease, and one patient (#5) with a jejunostomy 60 cm distal from the DJF following generalized peritonitis.
All of the subjects had normal liver and renal function at the time of the study. They were receiving no medications known to influence gastrointestinal motility. The study was performed more than 3 months after surgery in the patients.
After an overnight fast, 200 ml of a liquid meal (YH-80, Meiji Milk Co. Ltd, Japan) mixed with 1500 mg dose of paracetamol powder (Pyrinazin, Yamanouchi Pharmaceutical Co. Ltd, Japan) was administered orally. The subjects remained supine until the end of the study. The liquid meal contained 6.2 g protein, 5 .2 g fat, and 32.2 g carbohydrate. Its pH, osmolarity, and total caloric value were approximately 3.9, 1000 mosm ml-', and 100 kcal ml-', respectively. No food, drink, or tobacco was permitted during the study.
Venous blood samples were drawn by venepuncture and placed in glass tubes. They were collected prior to, and 30, 60, 120 and 180 min after drug dosage. The blood was centrifuged and the serum was separated and stored immediately at -20°C until assay by h.p.l.c. based on the method described by Ameer et al. [8] .
Informed consent was obtained from all of the subjects, and the studies were carried out in accordance with the Declaration of Helsinki of 1975.
AUC(0,180 min) values were estimated using the linear trapezoidal rule. Results are given as mean ± s.d. Statistical comparisons were performed using Student's t-test, with P < 0.05 regarded as significant.
Results
Mean serum paracetamol concentrations in each group are shown in Figure 1 . The highest concentrations were observed in the 30 min sample in Groups B and C and in the 120 min sample in Groups A, D and E. Mean (± s.d.) concentrations at these times were 18.90 ± 1.55 ,ug ml-' (Group B), 12.89 ± 2.12 ,ug ml-' (Group C), 11.12 ± 3.16 jig ml-' (Group A), 9.78 ± 2.85 jg ml-' ( The concentration at 30 min was significantly higher in Groups B and C compared with the other groups (95% confidence intervals (CI) for differences from Group A were 12.12~15.18 and 5.92~9.36, respectively). The 30 min concentrations were significantly higher in Group B compared with Group C (95% CI for difference was 3.93~8.09). The 120 min concentrations were significantly lower in Group E compared with Group A (95% CI for difference was 4.19~8.27), and the difference between Group A and D was not significant (95% CI for difference was -0.61~3.29). Significant differences were observed in AUC(0,180) between Group A and E and between Group D and E (95% CI for differences were 11.05%17.79 and 7.00~15.04, respectively). The difference between Group A and D was not significant (95% CI for difference was -0.39~7.19).
Discussion
The healthy subjects and partially gastrectomized patients had intact or partially intact stomachs and intact small intestines including the duodenum; patients after PPPD with Billroth I type reconstruction had complete gastrointestinal tracts, excluding the middle section of the duodenum; short bowel syndrome patients had intact stomachs and duodenum but limited lengths of jejunum; and totally gastrectomized patients had small intestines approximately 20 cm distal from the duodenojejunal flexure. Because of the loss of the pyloric ring, the test meal containing paracetamol entered the duodenum and the jejunum in partially gastrectomized patients, and the jejunum in totally gastrectomized patients. An early maximum serum drug concentration in patients with total gastrectomy was presumably a result of the absence of a delaying effect on absorption from the intestine of gastric emptying. Rapid gastric emptying is indicated in the partial gastrectomy group by an early maximum serum drug concentration. A lower value of this concentration compared with the total gastrectomy group suggests slower absorption from the residual stomach and duodenum. In patients after PPPD with Billroth I type reconstruction, the serum drug concentration-time curve was similar to that in healthy subjects, suggesting that the middle section of the duodenum does not play an important role in paracetamol absorption. In short bowel syndrome patients, the extent of absorption of paracetamol appeared to be decreased compared with absorption in healthy subjects and patients after PPPD, emphasising the role of the jejunum as an absorption site. The data indicate that the main absorption site of oral paracetamol is the jejunum distal from the duodenojejunal flexure.
